Evidence map›Paper›PMID 26493377›Full record

ArticleMedical & biological engineering & computing2016

A comprehensive compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects.

O Vahidi, K E Kwok, R B Gopaluni, F K Knop

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

O VahidiSchool of Chemical Engineering, Iran University of Science and Technology, Narmak, Tehran, Iran.
K E KwokDepartment of Chemical and Biological Engineering, University of British Columbia, 2360 East Mall, Vancouver, BC, V6T1Z3, Canada. ezra@chbe.ubc.ca.
R B GopaluniDepartment of Chemical and Biological Engineering, University of British Columbia, 2360 East Mall, Vancouver, BC, V6T1Z3, Canada.
F K KnopCenter for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, 2900, Hellerup, Denmark.
University of British Columbia · CAIran University of Science and Technology · IRUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have expanded a former compartmental model of blood glucose regulation for healthy and type 2 diabetic subjects. The former model was a detailed physiological model which considered the interactions of three substances, glucose, insulin and glucagon on regulating the blood sugar. The main drawback of the former model was its restriction on the route of glucose entrance to the body which was limited to the intravenous glucose injection. To handle the oral glucose intake, we have added a model of glucose absorption in the gastrointestinal tract to the former model to address the resultant variations of blood glucose concentrations following an oral glucose intake. Another model representing the incretins production in the gastrointestinal tract along with their hormonal effects on boosting pancreatic insulin production is also added to the former model. We have used two sets of clinical data obtained during oral glucose tolerance test and isoglycemic intravenous glucose infusion test from both type 2 diabetic and healthy subjects to estimate the model parameters and to validate the model results. The estimation of model parameters is accomplished through solving a nonlinear optimization problem. The results show acceptable precision of the estimated model parameters and demonstrate the capability of the model in accurate prediction of the body response during the clinical studies.

Indexed as

Models, BiologicalBlood GlucoseClinical Trials as TopicDiabetes Mellitus, Type 2FemaleGastrointestinal TractGlucoseGlucose Tolerance TestHumansIncretinsMaleModels, TheoreticalReproducibility of ResultsBlood GlucoseGlucoseIncretinsCompartmental modelIncretinsNonlinear optimizationOral glucose tolerance testParameter estimationType 2 diabetes mellitus

Identifiers

PMID26493377
OpenAlexW2177650849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.